Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Phone: (M) +45 6141 8634 Linkedin

    New Updates in Drug Formulation & Bioavailability

    The pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new and enabling formulation approaches.

    Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic at this meeting featuring about 100 delegates and 10 exhibitors. 

    New updates in Drug Formulation & Bioavailability is a platform based on the concept of synergies between “science” and “business”. The presented content and topics will focus on advancements in formulations and cutting edge technologies that can allow cheaper, safer and effective drugs.

    Date: April 3rd, 2019
    Time: 8:30  – 17:00 
    Venue: Edvard Thomsens Vej 14, Ørestaden, DK-2300 København S


    Among the speakers:

    Korbinian Löbmann
    Associate Professor Department of Pharmacy, University of Copenhagen
    Dr Finn Bauer
    Head of Solid Formulations R&D, Merck
    Solubility Enhancement through Silica Carrier Materials – Graduating from Lab Scale to Manufacturing
    Henrik Palmelund
    PhD Fellow, MSc Pharm University of Copenhagen
    Deep eutectic solvents: a potential tailor-made excipients approach for poorly soluble drugs?

    Jorrit Jeroen Water
    Principal Scientist, Oral Formulation Research, Novo Nordisk A/S
    Oral delivery of peptides and proteins

    Jukka Rantanen
    Professor, Manufacturing and Materials Research Group, University of Copenhagen
    Innovative manufacturing of personalized medicine
    Sami Svanbäck
    The Solubility Company, Helsinki
    Redefining Solubility Analysis – Image-based Measurement Using the SPA Method
    Anders Broo
    PhD, Senior Principal Scientist, IMED Biotech Unit, AstraZeneca Gothenburg
    Predictive modeling and AI/ML in discovery and development at AstraZeneca

    The target audience consists of:
    Drug formulation professionals from Big Pharma, CDMO’s, Academia
    Early Phase & virtual biotech and pharma companies
    QA & Reg Aff. Managers
    Procurement Managers
    Speakers will come from:
    Pharmaceutical companies, Excipient manufacturers, CDMO’s, Academia

    Topics will include:
    – Formulation development design space
    – Improving bioavailability of poorly soluble compounds
    – Controlled and modified release technologies
    – Out-sourcing and in-licensing
    – Exploring different routes of administration in enhancing macromolecule delivery